Astec Lifesciences Share PriceAstec Lifesciences

₹1342.1
17.7 (1.34%)
  • Advice
  • Hold
As on 23 September, 2023 | 00:54 BSE: 533138 NSE: ASTECISIN: INE563J01010

Astec Lifesciences Performance

Day Range

  • Low 1305
  • High 1366
1342.1

52 Week Range

  • Low 1045
  • High 2288.8
1342.1
  • Open Price1330
  • Previous Close1324.4
  • Volume12857

Start SIP in Astec Lifesciences

Start SIP

Astec Lifesciences Share Price

  • Over 1 Month -0.37%
  • Over 3 Month -1.01%
  • Over 6 Month 11.17%
  • Over 1 Year -29.19%

Astec Lifesciences Key Statistics

P/E Ratio 440.8
PEG Ratio -4.7
Market Cap Cr 2,632
Price to Book Ratio 6.3
EPS 13.2
Dividend 0.1
Relative Strength Index 45.44
Money Flow Index 32.73
MACD Signal 12.01
Average True Range 46.31

Astec Lifesciences Investment Rating

  • Master Rating:
  • Astec Lifesciences has an operating revenue of Rs. 586.75 Cr. on a trailing 12-month basis. An annual revenue de-growth of -7% needs improvement, Pre-tax margin of 6% is okay, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 18 which is a POOR score indicating inconsistency in earnings, a RS Rating of 13 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 139 indicates it belongs to a poor industry group of Chemicals-Agricultural and a Master Score of D is close to being the worst. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Astec Lifesciences Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 143127117200184272
Operating Expenses Qtr Cr 140122105166159207
Operating Profit Qtr Cr 3512332565
Depreciation Qtr Cr 9898911
Interest Qtr Cr 666543
Tax Qtr Cr -3-106415
Net Profit Qtr Cr -8-51181143
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 641687
Operating Expenses Annual Cr 552522
Operating Profit Annual in Cr 76154
Depreciation Cr 3434
Interest Annual Cr 219
Tax Annual Cr 931
Net Profit Annual Cr 2690
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 7423
Cash from Investing Activity Annual Cr -112-104
Cash from Financing Annual Activity Cr 3880
Net Cash Flow Annual Cr 00
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 419396
Fixed Assets Annual Cr 445363
Total Non Current Assets Annual Cr 481379
Total Current Assets Annual Cr 498518
Total Assets Annual Cr 979897
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 214202
ROE Annual % 623
ROCE Annual % 1232
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1424
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 143127117200184272
Operating Expenses Qtr Cr 140122105166159207
Operating Profit Qtr Cr 3512332565
Depreciation Qtr Cr 9898911
Interest Qtr Cr 666543
Tax Qtr Cr -3-106415
Net Profit Qtr Cr -8-51181143
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 641687
Operating Expenses Annual Cr 552522
Operating Profit Annual in Cr 76154
Depreciation Cr 3434
Interest Annual Cr 219
Tax Annual Cr 931
Net Profit Annual Cr 2690
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 7524
Cash from Investing Activity Annual Cr -113-104
Cash from Financing Annual Activity Cr 3880
Net Cash Flow Annual Cr 00
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 419396
Fixed Assets Annual Cr 445363
Total Non Current Assets Annual Cr 481381
Total Current Assets Annual Cr 499516
Total Assets Annual Cr 979897
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 214202
ROE Annual % 623
ROCE Annual % 1232
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1424

Astec Lifesciences Technicals

EMA & SMA

Current Price
₹1342.1
17.7 (1.34%)
  • Bullish Moving Average
  • ___
  • 1
  • Bearish Moving Average
  • ___
  • 15
  • 20 Day
  • ₹1367.05
  • 50 Day
  • ₹1356.05
  • 100 Day
  • ₹1372.06
  • 200 Day
  • ₹1447.21
  • 20 Day
  • ₹1383.56
  • 50 Day
  • ₹1333.93
  • 100 Day
  • ₹1359.97
  • 200 Day
  • ₹1429.91

Astec Lifesciences Resistance and Support

PIVOT
₹1337.7
Resistance
First Resistance ₹1370.4
Second Resistance ₹1398.7
Third Resistance ₹1431.4
RSI 45.44
MFI 32.73
MACD Single Line 12.01
MACD 1.35
Support
First Resistance ₹1309.41
Second Resistance ₹1276.7
Third Resistance ₹1248.41

Astec Lifesciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 13,931 736,393 52.86
Week 9,052 496,154 54.81
1 Month 17,279 877,783 50.8
6 Month 42,883 1,404,847 32.76

Astec Lifesciences Result Highlights

Astec Lifesciences Synopsis

NSE-Chemicals-Agricultural

Astec Lifesciences L is involved in the business activities of Manufacture of insecticides, rodenticides, fungicides, herbicides. Company’s Total Operating Revenue is Rs. 628.17 Cr. and Equity Capital is Rs. 19.61 Cr. for the Year ended 31/03/2023. Astec Lifesciences Ltd. is a Public Limited Listed company incorporated on 25/01/1994 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1994PLC076236 and registration number is 076236.
Market Cap 2,632
Sales 587
Shares in Float 0.65
No of funds 35
Yield 0.11
Book Value 6.27
U/D Vol ratio 2.1
LTDebt / Equity 3
Alpha -0.16
Beta 0.77

Astec Lifesciences

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters 66.76%66.77%66.77%66.77%
Mutual Funds 9.14%9.57%8.45%8.71%
Foreign Portfolio Investors 1.95%2.29%2.19%1.53%
Financial Institutions/ Banks
Individual Investors 17.75%16.81%17.86%18.02%
Others 4.4%4.56%4.73%4.97%

Astec Lifesciences Management

Name Designation
Mr. Nadir B Godrej Chairman
Mr. Ashok V Hiremath Non Executive Director
Mr. Balram Singh Yadav Non Executive Director
Mr. Anurag Roy WholeTime Director & CEO
Dr. Brahma Nand Vyas Independent Director
Mr. Vijay Kashinath Khot Independent Director
Mr. R R Govindan Independent Director
Mr. Nandkumar Dhekne Independent Director
Ms. Anjali Gupte Independent Director
Mr. Burjis Nadir Godrej Non Executive Director

Astec Lifesciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Astec Lifesciences Corporate Action

Date Purpose Remarks
2023-07-27 Quarterly Results
2023-05-02 Audited Results & Final Dividend
2023-01-30 Quarterly Results & Others Inter alia, the Board may also consider and approve issuance of Debentures or debt securities upto such limit as may be deemed appropriate and approved by the Board. per share(15%)Final Dividend
2022-10-28 Quarterly Results
2022-07-25 Quarterly Results

Astec Lifesciences MF Shareholding

Name Amount(cr)
Nippon India Small Cap Fund - Growth 36540
Nippon India Multi Cap Fund - Growth 20192
ICICI Prudential Multicap Fund Growth 8564
ICICI Prudential Smallcap Fund Growth 6989
ICICI Prudential MidCap Fund Growth 4317
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Astec Lifesciences FAQs

What is Share Price of Astec Lifesciences ?

Astec Lifesciences share price is ₹1342 As on 23 September, 2023 | 00:40

What is the Market Cap of Astec Lifesciences ?

The Market Cap of Astec Lifesciences is ₹2631.8 Cr As on 23 September, 2023 | 00:40

What is the P/E ratio of Astec Lifesciences ?

The P/E ratio of Astec Lifesciences is 440.8 As on 23 September, 2023 | 00:40

What is the PB ratio of Astec Lifesciences ?

The PB ratio of Astec Lifesciences is 6.3 As on 23 September, 2023 | 00:40

Q2FY23